BRPI1007883A2 - sal, e, cristal. - Google Patents
sal, e, cristal.Info
- Publication number
- BRPI1007883A2 BRPI1007883A2 BRPI1007883A BRPI1007883A BRPI1007883A2 BR PI1007883 A2 BRPI1007883 A2 BR PI1007883A2 BR PI1007883 A BRPI1007883 A BR PI1007883A BR PI1007883 A BRPI1007883 A BR PI1007883A BR PI1007883 A2 BRPI1007883 A2 BR PI1007883A2
- Authority
- BR
- Brazil
- Prior art keywords
- salt
- crystal
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15561309P | 2009-02-26 | 2009-02-26 | |
| JP2009043268 | 2009-02-26 | ||
| PCT/JP2010/053372 WO2010098490A1 (en) | 2009-02-26 | 2010-02-24 | Salt of tetrahydrotriazolopyridine derivative and crystal thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1007883A2 true BRPI1007883A2 (pt) | 2016-02-23 |
Family
ID=42126410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1007883A BRPI1007883A2 (pt) | 2009-02-26 | 2010-02-24 | sal, e, cristal. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8703954B2 (pt) |
| EP (1) | EP2401277A1 (pt) |
| JP (1) | JP5580816B2 (pt) |
| KR (1) | KR20110118626A (pt) |
| CN (1) | CN102333778B (pt) |
| AU (1) | AU2010218667A1 (pt) |
| BR (1) | BRPI1007883A2 (pt) |
| CA (1) | CA2749702A1 (pt) |
| IL (1) | IL213973A0 (pt) |
| MX (1) | MX2011006782A (pt) |
| WO (1) | WO2010098490A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7667041B2 (en) * | 2004-05-26 | 2010-02-23 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
| US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| US9453000B2 (en) | 2007-08-31 | 2016-09-27 | Eisai R&D Management Co., Ltd. | Polycyclic compound |
| US8754100B2 (en) | 2009-02-26 | 2014-06-17 | Eisai R&D Management Co., Ltd. | Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
| EP2691393B1 (en) | 2011-03-31 | 2016-09-14 | Pfizer Inc | Novel bicyclic pyridinones |
| UA110688C2 (uk) | 2012-09-21 | 2016-01-25 | Пфайзер Інк. | Біциклічні піридинони |
| ES2818806T3 (es) | 2015-02-03 | 2021-04-14 | Pfizer | Novedosas ciclopropabenzofuranil piridopirazindionas |
| CN113416188B (zh) * | 2021-05-31 | 2022-12-13 | 河南偶联生物科技有限公司 | 一种[1,2,4]三唑并[1,5-a]吡啶化合物的合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1628666B1 (en) | 2003-05-14 | 2015-09-23 | NeuroGenetic Pharmaceuticals, Inc. | Compouds and uses thereof in modulating amyloid beta |
| US7667041B2 (en) | 2004-05-26 | 2010-02-23 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
| KR20080069221A (ko) | 2005-11-24 | 2008-07-25 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 모르폴린 타입의 신나미드 화합물 |
| TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| MX2008011221A (es) | 2006-03-09 | 2008-09-11 | Eisai R&D Man Co Ltd | Compuestos de cinamida policiclicos. |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| PE20081791A1 (es) | 2007-02-28 | 2009-02-07 | Eisai Randd Man Co Ltd | Dos derivados ciclicos de oxomorfolina |
| US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| US9453000B2 (en) * | 2007-08-31 | 2016-09-27 | Eisai R&D Management Co., Ltd. | Polycyclic compound |
| CN102137855A (zh) * | 2008-08-27 | 2011-07-27 | 卫材R&D管理有限公司 | 制备某些肉桂酰胺化合物的方法 |
| WO2010096488A1 (en) | 2009-02-17 | 2010-08-26 | The Regents Of The University Of California | Method of reducing acetylation in plants to improve biofuel production |
| JP2012051806A (ja) | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | イミダゾリルピラジン誘導体 |
| UA105923C2 (uk) | 2009-02-26 | 2014-07-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Сполуки як антагоністи брадикініну b1 |
| PL2401270T3 (pl) | 2009-02-26 | 2014-03-31 | Glaxo Group Ltd | Pochodne pirazolu stosowane jako antagoniści receptora CCR4 |
| CA2778517A1 (en) | 2009-07-15 | 2011-01-20 | Janssen Pharmaceuticals, Inc. | Substituted triazole and imidazole derivatives as gamma secretase modulators |
-
2010
- 2010-02-24 JP JP2011514997A patent/JP5580816B2/ja not_active Expired - Fee Related
- 2010-02-24 EP EP10708826A patent/EP2401277A1/en not_active Withdrawn
- 2010-02-24 WO PCT/JP2010/053372 patent/WO2010098490A1/en active Application Filing
- 2010-02-24 MX MX2011006782A patent/MX2011006782A/es active IP Right Grant
- 2010-02-24 US US13/143,130 patent/US8703954B2/en not_active Expired - Fee Related
- 2010-02-24 AU AU2010218667A patent/AU2010218667A1/en not_active Abandoned
- 2010-02-24 BR BRPI1007883A patent/BRPI1007883A2/pt not_active IP Right Cessation
- 2010-02-24 CN CN201080009393.2A patent/CN102333778B/zh not_active Expired - Fee Related
- 2010-02-24 CA CA2749702A patent/CA2749702A1/en not_active Abandoned
- 2010-02-24 KR KR1020117015845A patent/KR20110118626A/ko not_active Application Discontinuation
-
2011
- 2011-07-07 IL IL213973A patent/IL213973A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102333778A (zh) | 2012-01-25 |
| KR20110118626A (ko) | 2011-10-31 |
| AU2010218667A1 (en) | 2011-07-21 |
| CN102333778B (zh) | 2015-05-13 |
| IL213973A0 (en) | 2011-08-31 |
| EP2401277A1 (en) | 2012-01-04 |
| JP5580816B2 (ja) | 2014-08-27 |
| CA2749702A1 (en) | 2010-09-02 |
| WO2010098490A1 (en) | 2010-09-02 |
| US20110275822A1 (en) | 2011-11-10 |
| JP2012519151A (ja) | 2012-08-23 |
| MX2011006782A (es) | 2011-07-20 |
| US8703954B2 (en) | 2014-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2447254I2 (lt) | Kristalai | |
| DK2720617T4 (da) | Vævsbeholder / beholderaggregat og dertil knyttet fremgangsmåde. | |
| BRPI1011886A2 (pt) | solução contendo ácido hiplocloroso e métodos do uso do mesmo. | |
| BRPI1014650A2 (pt) | molas espiral-em-espiral e molas interiores. | |
| BRPI1012883A2 (pt) | dispositivo intercorporal. | |
| BR112013015783A2 (pt) | autoinjetor. | |
| IT1400425B1 (it) | Modified snrnas for use in therapy. | |
| BRPI1016117A8 (pt) | derivados de isoxazol-isoxazol e isoxazol-isotiazol. | |
| BR112012000281A2 (pt) | proteína quimérica. | |
| BRPI1007883A2 (pt) | sal, e, cristal. | |
| BRPI0807004A2 (pt) | Sal | |
| IT1396487B1 (it) | Convogliatore. | |
| DK2442870T3 (da) | Pyrazinooxazepin-derivater. | |
| IT1398747B1 (it) | Oscillatore. | |
| BRPI1006990A2 (pt) | planejador compartilhado | |
| BRPI1008952A2 (pt) | Composição herbicida. | |
| IT1394476B1 (it) | Metodo per prevenire e controllare il biofouling. | |
| FR2942385B1 (fr) | Grille-pain. | |
| IT1401887B1 (it) | Elettrovalvola. | |
| BRPI1008675A2 (pt) | grânulos. | |
| FR2946246B1 (fr) | Fauteuil roulant. | |
| BRPI0906688A2 (pt) | Sal, e, cristal | |
| ES1071429Y (es) | Estratificado de aglomerado de silice-cuarzo, cristal y resinas | |
| ES1073526Y (es) | Almohada. | |
| IT1401345B1 (it) | Bomboletta. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |